P3 Health Partners INC 10-Q quarterly reports
Quarterly reports, with unaudited financial statements and management’s discussion of the quarter just ended.
NASDAQ
P3 Health Partners Inc. filed its Q2 2026 Form 10-Q, revealing revenue growth but also substantial operating losses and significant financial challenges, including a going concern warning.
NASDAQ
P3 Health Partners Inc. filed its Form 10-Q for the quarter ended March 31, 2026, reporting a net income of $3.04 million, a significant improvement from a net loss of $44.25 million in the prior year period.
NASDAQ
P3 Health Partners Inc. reports continued net losses and a significant working capital deficit, raising substantial doubt about its ability to continue as a going concern, despite strategic contract terminations and new debt financing.
NASDAQ
P3 Health Partners Inc. reported increased net losses and declining revenue for Q2 2025, raising substantial doubt about its ability to continue as a going concern.
NASDAQ
P3 Health Partners' Q1 2025 revenue decreased by 4% year-over-year due to a reduction in at-risk members, despite efforts to manage medical expenses and improve operating efficiencies.
NASDAQ
P3 Health Partners reported a net loss of $102.9 million for Q3 2024, with substantial doubt about the company's ability to continue as a going concern.
NASDAQ
P3 Health Partners saw a 15% increase in revenue year-over-year in the second quarter of 2024, driven by membership growth, but continues to face challenges with profitability and internal controls.
NASDAQ
P3 Health Partners saw a 29% increase in revenue in the first quarter of 2024, driven by membership growth, but continues to experience net losses.